Kamada Ltd. has grown revenue 12% a year over three years and 6.3% a year over five. Revenue growth, 3-year annual rate: +12% (Drug Manufacturers - Specialty & Generic median +13%). Revenue growth, 5-year rate: +6.3%, growth has picked up over the last three years. Years of annual history on file: 11, FY2015 to FY2025, as filed.

KMDAKamada Ltd.

Healthcare

$7.78+21% 1Y

$7.78

$6.4152 weeks$9.04

Is it growing?

Excellent

Growing: revenue growing +12% year on year, earnings up +35% year on year, and operating margin widening (+2.1 points).

3 good

Revenue trend+12% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings.

Earnings trend+35% in a year

Trailing-twelve-month earnings per share against a year earlier. Growing faster than revenue, so margins or the share count are helping.

Margin direction+2.1 points operating

Trailing-twelve-month operating margin, 14.5% now against 12.4% a year earlier.

All from SEC EDGAR, as of Dec 31, 2025.

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is KMDA growing?

Kamada Ltd. has grown revenue 12% a year over three years and 6.3% a year over five.

+12%

Revenue growth, 3-year annual rate · Drug Manufacturers - Specialty & Generic median +13% · steady growth, ahead of inflation · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: +6.3%
Revenue growth, 5-year rate · +12% over three · growth has picked up over the last three years
Years of annual history on file: 11
Years of annual history on file · FY2015 to FY2025, as filed

Details›